Tìm theo
TAK-390MR
Các tên gọi khác (1) :
  • dexlansoprazole
enzyme inhibitors, anti ulcer agents, anti infective agents
Thuốc Gốc
Small Molecule
TAK-390MR is an investigational for the treatment of acid related disorders.. TAK-390MR employs a new modified release (MR) technology on an enantiomer of lansoprazole.
Cơ Chế Tác Dụng : TAK-390MR is an investigational for the treatment of acid related disorders.. TAK-390MR employs a new modified release (MR) technology on an enantiomer of lansoprazole. Lansoprazole has an asymmetric sulfur in its chemical structure and is commercially marketed as a racemic mixture. Both the (R)- and (S)-enantiomers of lansoprazole inhibit acid formation in isolated canine parietal cells and (H'+'/K'+')-ATPase in canine gastric microsomes with nearly the same potency.
Chỉ Định : Investigated for use/treatment in duodenal ulcers, gastric ulcers, gastroesophageal reflux disease (GERD), and gastrointestinal diseases and disorders (miscellaneous).
Dữ Kiện Thương Mại
Nhà Sản Xuất
  • Công ty :
    Sản phẩm biệt dược : Dexilant
  • Công ty :
    Sản phẩm biệt dược : Kapidex
Tài Liệu Tham Khảo Thêm
drugbank
http://www.drugbank.ca/drugs/DB05351
National Drug Code Directory
http://www.hipaaspace.com/Medical_Billing/Coding/National.Drug.Codes/PDF/54868-5998
... loading
... loading